Variant report
Variant | nsv972435 |
---|---|
Chromosome Location | chr9:102067448-102071368 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:31)
- CpG islands (count:61)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:31 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr9:102068594-102068644 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr9:102068407-102068813 | K562 | blood: | n/a | n/a |
3 | CTCF | chr9:102068540-102068690 | HepG2 | liver: | n/a | n/a |
4 | CTCF | chr9:102068542-102068654 | MCF-7 | breast: | n/a | n/a |
5 | CTCF | chr9:102068545-102068650 | MCF-7 | breast: | n/a | n/a |
6 | CTCF | chr9:102068595-102068637 | Fibrobl | skin: | n/a | n/a |
7 | CTCF | chr9:102068548-102068656 | Hela-S3 | cervix: | n/a | n/a |
8 | CTCF | chr9:102068480-102068630 | K562 | blood: | n/a | n/a |
9 | CTCF | chr9:102069832-102069866 | GM13976 | blood: | n/a | n/a |
10 | CTCF | chr9:102068589-102068640 | GM12892 | blood: | n/a | n/a |
11 | CTCF | chr9:102068546-102068661 | K562 | blood: | n/a | n/a |
12 | CTCF | chr9:102068540-102068690 | K562 | blood: | n/a | n/a |
13 | CTCF | chr9:102068555-102068659 | MCF-7 | breast: | n/a | n/a |
14 | CTCF | chr9:102068584-102068649 | A549 | lung: | n/a | n/a |
15 | CTCF | chr9:102068408-102068582 | K562 | blood: | n/a | n/a |
16 | CTCF | chr9:102068534-102068672 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | GATA3 | chr9:102070101-102070676 | MCF-7 | breast: | n/a | chr9:102070140-102070150 |
18 | MAX | chr9:102070215-102070522 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | MAZ | chr9:102068905-102069014 | K562 | blood: | n/a | n/a |
20 | POLR2A | chr9:102068454-102068502 | MCF-7 | breast: | n/a | n/a |
21 | POLR2A | chr9:102067646-102067915 | A549 | lung: | n/a | n/a |
22 | POLR2A | chr9:102068161-102068383 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr9:102067648-102067797 | A549 | lung: | n/a | n/a |
24 | POLR2A | chr9:102068473-102068572 | A549 | lung: | n/a | n/a |
25 | POLR2A | chr9:102068396-102068450 | MCF-7 | breast: | n/a | n/a |
26 | SP1 | chr9:102070153-102070508 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | SP1 | chr9:102070133-102070585 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | TCF7L2 | chr9:102070129-102070541 | MCF-7 | breast: | n/a | chr9:102070269-102070276 |
29 | UBTF | chr9:102068848-102068944 | K562 | blood: | n/a | n/a |
30 | YY1 | chr9:102070248-102070534 | ECC-1 | luminal epithelium: | n/a | n/a |
31 | ZNF217 | chr9:102070251-102070507 | MCF-7 | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:102068578-102068628 | Hepatocyte | liver: | n/a |
2 | chr9:102068578-102068628 | A549 | lung: | n/a |
3 | chr9:102068578-102068628 | MCF-7 | breast: | n/a |
4 | chr9:102068578-102068628 | NHBE | bronchial: | n/a |
5 | chr9:102068578-102068628 | HPAEpiC | pulmonary alveolar: | n/a |
6 | chr9:102068578-102068628 | T-47D | breast: | n/a |
7 | chr9:102068578-102068628 | PFSK-1 | brain: | n/a |
8 | chr9:102068578-102068628 | SK-N-SH_RA | brain: | n/a |
9 | chr9:102068578-102068628 | AG10803 | skin: | n/a |
10 | chr9:102068578-102068628 | HEEpiC | esophagus: | n/a |
11 | chr9:102068578-102068628 | LNCaP | prostate: | n/a |
12 | chr9:102068578-102068628 | MCF10A-Er-Src | breast: | n/a |
13 | chr9:102068578-102068628 | H1-hESC | embryonic stem cell: | embryo |
14 | chr9:102068578-102068628 | GM12878 | blood: | n/a |
15 | chr9:102068578-102068628 | HCM | heart: | n/a |
16 | chr9:102068578-102068628 | BJ | skin: | n/a |
17 | chr9:102068578-102068628 | SK-N-MC | brain: | n/a |
18 | chr9:102068578-102068628 | HRPEpiC | eye: | n/a |
19 | chr9:102068578-102068628 | ProgFib | skin: | n/a |
20 | chr9:102068578-102068628 | AG09319 | gingival: | n/a |
21 | chr9:102068578-102068628 | NHDF-neo | bronchial: | n/a |
22 | chr9:102068578-102068628 | CMK | blood: | n/a |
23 | chr9:102068578-102068628 | HCF | heart: | n/a |
24 | chr9:102068578-102068628 | HCPEpiC | choroid plexus: | n/a |
25 | chr9:102068578-102068628 | PrEC | prostate: | n/a |
26 | chr9:102068578-102068628 | AG04450 | lung: | fetal |
27 | chr9:102068578-102068628 | HepG2 | liver: | n/a |
28 | chr9:102068578-102068628 | NH-A | brain: | n/a |
29 | chr9:102068578-102068628 | Jurkat | blood: | n/a |
30 | chr9:102068578-102068628 | GM12891 | blood: | n/a |
31 | chr9:102068578-102068628 | Hela-S3 | cervix: | n/a |
32 | chr9:102068578-102068628 | NB4 | blood: | n/a |
33 | chr9:102068578-102068628 | HNPCEpiC | eye: | n/a |
34 | chr9:102068578-102068628 | GM19239 | blood: | n/a |
35 | chr9:102068578-102068628 | ECC-1 | luminal epithelium: | n/a |
36 | chr9:102068578-102068628 | K562 | blood: | n/a |
37 | chr9:102068578-102068628 | U87 | brain: | n/a |
38 | chr9:102068578-102068628 | GM12892 | blood: | n/a |
39 | chr9:102068578-102068628 | Caco-2 | colon: | n/a |
40 | chr9:102068578-102068628 | HRCEpiC | kidney: | n/a |
41 | chr9:102068578-102068628 | BE2_C | brain: | n/a |
42 | chr9:102068578-102068628 | HMEC | breast: | n/a |
43 | chr9:102068578-102068628 | GM06990 | blood: | n/a |
44 | chr9:102068578-102068628 | HCT-116 | colon: | n/a |
45 | chr9:102068578-102068628 | PANC-1 | pancreas: | n/a |
46 | chr9:102068578-102068628 | HAEpiC | amniotic membrane: | n/a |
47 | chr9:102068578-102068628 | RPTEC | kidney: | n/a |
48 | chr9:102068578-102068628 | AG09309 | skin: | n/a |
49 | chr9:102068578-102068628 | HUVEC | blood vessel: | n/a |
50 | chr9:102068578-102068628 | SK-N-SH | brain: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:5173465..5176142-chr9:102070629..102072534,2 | MCF-7 | breast: | |
2 | chr9:102067677..102069694-chr9:102073108..102075861,2 | K562 | blood: | |
3 | chr9:101982802..101985328-chr9:102065308..102068359,3 | MCF-7 | breast: | |
4 | chr9:102071163..102073683-chr9:102075008..102078219,3 | K562 | blood: | |
5 | chr9:102071163..102073837-chr9:102075746..102078549,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KRT8P11 | TF binding region |
KRT8P11 | CpG island |
ENSG00000119523 | chromatin interactions |
ENSG00000106803 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs55831955 | chr9:102067454-102067455 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs115828323 | chr9:102067467-102067468 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs573465801 | chr9:102067494-102067495 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs542549573 | chr9:102067516-102067517 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs562240126 | chr9:102067517-102067518 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs41274650 | chr9:102067523-102067524 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs544782639 | chr9:102067531-102067532 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs151087474 | chr9:102067532-102067533 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs538582948 | chr9:102067545-102067546 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs532198342 | chr9:102067554-102067555 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs377222536 | chr9:102067570-102067571 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs191553733 | chr9:102067574-102067575 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs376610753 | chr9:102067581-102067582 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs559341752 | chr9:102067598-102067599 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs200912320 | chr9:102067629-102067630 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs548495161 | chr9:102067634-102067635 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs568246625 | chr9:102067729-102067730 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs536860833 | chr9:102067732-102067733 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs550331506 | chr9:102067744-102067745 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs570613362 | chr9:102067749-102067750 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs143577538 | chr9:102067769-102067770 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs184339282 | chr9:102067820-102067821 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs573236062 | chr9:102067825-102067826 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs535459061 | chr9:102067838-102067839 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs556040214 | chr9:102067839-102067840 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs575820450 | chr9:102067849-102067850 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs544824025 | chr9:102067851-102067852 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs370753917 | chr9:102067866-102067867 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs578211778 | chr9:102067871-102067872 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs395420 | chr9:102067887-102067888 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs559165580 | chr9:102067907-102067908 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs528126167 | chr9:102067912-102067913 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs547839041 | chr9:102067922-102067923 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs554708998 | chr9:102067933-102067934 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs562034250 | chr9:102068021-102068022 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs187226014 | chr9:102068031-102068032 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs550368534 | chr9:102068042-102068043 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs184437 | chr9:102068058-102068059 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs535596627 | chr9:102068092-102068093 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs547098975 | chr9:102068098-102068099 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs146806350 | chr9:102068138-102068139 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs535864596 | chr9:102068161-102068162 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs555429273 | chr9:102068168-102068169 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs372233021 | chr9:102068199-102068200 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs576018193 | chr9:102068202-102068203 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs61910688 | chr9:102068211-102068212 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs75723368 | chr9:102068232-102068233 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs558488285 | chr9:102068255-102068256 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs578232454 | chr9:102068277-102068278 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs540457498 | chr9:102068280-102068281 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Nicotine dependence | 17160897 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Fukuyama congenital muscular dystrophy | 21572526 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:102059200-102068600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr9:102061800-102069400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr9:102062400-102070200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr9:102066400-102068000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr9:102066600-102069800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr9:102066800-102069800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr9:102068000-102068200 | Bivalent Enhancer | K562 | blood |
8 | chr9:102068000-102070200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr9:102068600-102069000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr9:102069400-102070400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr9:102069600-102070800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
12 | chr9:102069800-102070200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr9:102069800-102070200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr9:102069800-102070400 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr9:102069800-102070400 | Enhancers | Placenta | Placenta |
16 | chr9:102069800-102070600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr9:102069800-102070600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr9:102069800-102070800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr9:102070000-102070200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr9:102070000-102070600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr9:102070200-102070600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
22 | chr9:102070200-102071200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
23 | chr9:102070800-102071400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
24 | chr9:102071200-102072400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |